These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23761553)

  • 1. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
    Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
    Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.
    Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
    PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of tumor blood flow changes in a murine breast cancer model after adriamycin chemotherapy using contrast-enhanced destruction-replenishment sonography.
    Wang JW; Zheng W; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
    J Ultrasound Med; 2013 Apr; 32(4):683-90. PubMed ID: 23525395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound.
    Chen Y; Han F; Cao LH; Li C; Wang JW; Li Q; Zheng W; Guo ZX; Li AH; Zhou JH
    BMC Cancer; 2015 Mar; 15():136. PubMed ID: 25884471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: preliminary results with a mouse hepatoma model.
    Zhou JH; Cao LH; Zheng W; Liu M; Han F; Li AH
    AJR Am J Roentgenol; 2011 Jan; 196(1):W13-7. PubMed ID: 21178025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
    Zhang P; Chen Y; Liu J; Yang Y; Lv Q; Wang J; Zhang L; Xie M
    Ultrasound Med Biol; 2018 Apr; 44(4):840-852. PubMed ID: 29395676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.
    Zhou JH; Zheng W; Cao LH; Liu M; Luo RZ; Han F; Wu PH; Li AH
    Eur J Radiol; 2012 Jun; 81(6):1360-5. PubMed ID: 21345633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonic spectrum analysis for in vivo characterization of tumor microstructural changes in the evaluation of tumor response to chemotherapy using diagnostic ultrasound.
    Lin CY; Cao LH; Wang JW; Zheng W; Chen Y; Feng ZZ; Li AH; Zhou JH
    BMC Cancer; 2013 Jun; 13():302. PubMed ID: 23800247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
    Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
    Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Super-Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer.
    Hoyt K
    J Ultrasound Med; 2024 Jun; 43(6):1099-1107. PubMed ID: 38411352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound imaging of breast tumor perfusion and neovascular morphology.
    Hoyt K; Umphrey H; Lockhart M; Robbin M; Forero-Torres A
    Ultrasound Med Biol; 2015 Sep; 41(9):2292-302. PubMed ID: 26116159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring parotid gland tumors with a new perfusion software for contrast-enhanced ultrasound.
    Klotz LV; Ingrisch M; Eichhorn ME; Niemoeller O; Siedek V; Gürkov R; Clevert DA
    Clin Hemorheol Microcirc; 2014; 58(1):261-9. PubMed ID: 25339101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic tumor treatment: noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound.
    Zhou J; Zheng W; Cao L; Liu M; Han F; Li A
    Acad Radiol; 2010 May; 17(5):646-51. PubMed ID: 20223684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
    Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
    Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative perfusion analysis in pancreatic contrast enhanced ultrasound (DCE-US): a promising tool for the differentiation between autoimmune pancreatitis and pancreatic cancer.
    Vitali F; Pfeifer L; Janson C; Goertz RS; Neurath MF; Strobel D; Wildner D
    Z Gastroenterol; 2015 Oct; 53(10):1175-81. PubMed ID: 26480053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
    Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
    Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
    Merz M; Komljenovic D; Semmler W; Bäuerle T
    Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study.
    Gauthier M; Tabarout F; Leguerney I; Polrot M; Pitre S; Peronneau P; Lassau N
    J Ultrasound Med; 2012 Apr; 31(4):595-608. PubMed ID: 22441917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
    Zhou SC; Le J; Fan YW; Chen M; Chang C
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.